Global Neonatal Intensive Care Respiratory Devices Market OverviewThe global neonatal intensive care respiratory devices market is projected to grow at a compound annual growth rate of approximately 6 ...

Global Capnography Equipment Market OverviewThe global capnography equipment market is anticipated to grow at a steady pace with an estimated compound annual growth rate of around 5% over the next ...

In an open-label study of 29 men, including patients with ulcerative colitis and Crohn’s disease in remission, 6 g per day of curcumin for eight weeks led to modest, transient shifts in gut microbiota ...

In this single-center ambispective cohort of 283 Polish patients with COVID-19–related ARDS requiring invasive mechanical ventilation, cumulative mortality reached 44.5% at four years after ICU ...

EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Updated Phase 3 ARDS Results Continue to Show Mortality Benefit On February 24, 2026, Edesa Biotech, Inc. (NASDAQ:EDSA) announced additional Pha ...

Optimizing mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) remains a cornerstone of critical care. While the principles of lung-protective ventilation such as low ...

The framework shows how breath-by-breath and contextual information are processed by AI systems using physiological rules and learning algorithms to support clinical decisions—such as detecting ...

On October 28, 2025, Edesa Biotech, Inc. (NASDAQ:EDSA) announced positive results from the Phase 3 trial evaluating paridiprubart (EB05) in the treatment of acute respiratory distress syndrome (ARDS).

Rotating through the R Adams Crowley Shock Trauma Center in Baltimore was a rite of passage for critical care medicine fellows in my training program. Long before my visit, I’d heard about Dr Nader ...

Research exploring protective mechanical ventilation strategies for acute respiratory distress syndrome was presented at the ERS Congress by Luca Menga, MD, University of Toronto. Preclinical data ...

Acute respiratory distress syndrome (ARDS) is a life-threatening pulmonary condition marked by intense inflammation, alveolar damage and fluid accumulation in the lungs, often leading to respiratory ...